{"pmid":32333649,"title":"The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene.","text":["The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene.","Clin Chem Lab Med","Capoluongo, Ettore D","Amato, Felice","Castaldo, Giuseppe","32333649"],"journal":"Clin Chem Lab Med","authors":["Capoluongo, Ettore D","Amato, Felice","Castaldo, Giuseppe"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32333649","week":"202017|Apr 20 - Apr 26","doi":"10.1515/cclm-2020-0442","keywords":["covid-19","chloroquine","g6pd"],"source":"PubMed","topics":["Treatment","General Info"],"weight":1,"e_drugs":["Chloroquine"],"_version_":1665071049739337729,"score":8.518259,"similar":[{"pmid":32281268,"title":"G6PD and chloroquine: Selecting the treatment against SARS-CoV-2?","text":["G6PD and chloroquine: Selecting the treatment against SARS-CoV-2?","J Cell Mol Med","Kassi, Eva N","Papavassiliou, Kostas A","Papavassiliou, Athanasios G","32281268"],"journal":"J Cell Mol Med","authors":["Kassi, Eva N","Papavassiliou, Kostas A","Papavassiliou, Athanasios G"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281268","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jcmm.15312","keywords":["covid-19 (sars-cov-2)","g6pd","chloroquine","haemolysis","oxidative injury","pandemic","retinopathy"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Chloroquine"],"_version_":1664636703983271936,"score":252.26859},{"pmid":32325028,"title":"G6PD deficiency in COVID-19 pandemic: \"A ghost in the ghost\".","text":["G6PD deficiency in COVID-19 pandemic: \"A ghost in the ghost\".","Hematol Oncol Stem Cell Ther","Al-Abdi, Sameer","Al-Aamri, Maryam","32325028"],"journal":"Hematol Oncol Stem Cell Ther","authors":["Al-Abdi, Sameer","Al-Aamri, Maryam"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32325028","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.hemonc.2020.04.002","source":"PubMed","topics":["Prevention","Treatment"],"weight":1,"_version_":1664895932787851264,"score":172.49486},{"pmid":32281583,"title":"Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).","text":["Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).","Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established. Chloroquine and hydroxychloroquine have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Increasing evidence obtained from completed clinical studies indicates the prospects for chloroquine/hydroxychloroquine to treat COVID-19. More randomized control clinical studies are warranted to determine the feasibility of these two drugs in treating COVID-19.","Biosci Trends","Gao, Jianjun","Hu, Shasha","32281583"],"abstract":["Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established. Chloroquine and hydroxychloroquine have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Increasing evidence obtained from completed clinical studies indicates the prospects for chloroquine/hydroxychloroquine to treat COVID-19. More randomized control clinical studies are warranted to determine the feasibility of these two drugs in treating COVID-19."],"journal":"Biosci Trends","authors":["Gao, Jianjun","Hu, Shasha"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281583","week":"202016|Apr 13 - Apr 19","doi":"10.5582/bst.2020.03072","keywords":["covid-19","sars-cov-2","chloroquine","hydroxychloroquine"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Chloroquine","Hydroxychloroquine"],"_version_":1664636703909871617,"score":86.658844},{"pmid":32147496,"pmcid":"PMC7132364","title":"Of chloroquine and COVID-19.","text":["Of chloroquine and COVID-19.","Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.","Antiviral Res","Touret, Franck","de Lamballerie, Xavier","32147496"],"abstract":["Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research."],"journal":"Antiviral Res","authors":["Touret, Franck","de Lamballerie, Xavier"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32147496","week":"202011|Mar 09 - Mar 15","doi":"10.1016/j.antiviral.2020.104762","keywords":["2019-ncov","antiviral","covid-19","chloroquine","sars-cov-2"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Chloroquine"],"_version_":1664640874884104193,"score":77.46682},{"pmid":32194152,"pmcid":"PMC7156117","title":"Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.","text":["Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.","Int J Antimicrob Agents","Sahraei, Zahra","Shabani, Minoosh","Shokouhi, Shervin","Saffaei, Ali","32194152"],"journal":"Int J Antimicrob Agents","authors":["Sahraei, Zahra","Shabani, Minoosh","Shokouhi, Shervin","Saffaei, Ali"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32194152","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.ijantimicag.2020.105945","keywords":["covid-19","chloroquine","coronavirus","hydroxychloroquine"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Hydroxychloroquine","Chloroquine","Aminoquinolines"],"_version_":1664640930691416064,"score":74.20333}]}